M-M-R® II manufactured using recombinant human albumin (rHA) and M-M-R® II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children
Titel:
M-M-R® II manufactured using recombinant human albumin (rHA) and M-M-R® II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children
Auteur:
Wiedmann, Richard T. Reisinger, Keith S. Hartzel, Jonathan Malacaman, Edgardo Senders, Shelly D. Giacoletti, Katherine E.D. Shaw, Eric Kuter, Barbara J. Schödel, Florian Musey, Luwy K.